Workflow
医疗收购扩张
icon
Search documents
固生堂附属拟收购大中堂100%股权及相关权益
Zhi Tong Cai Jing· 2025-11-16 12:04
Core Viewpoint - Gushengtang Singapore TCM Healthcare Technologies Holdings Private Limited, a subsidiary of Gushengtang, has entered into a share transfer agreement to acquire 100% equity and related interests of DA ZHONG TANG PTE.LTD., which will become a subsidiary of the company upon completion of the acquisition [1] Group 1: Acquisition Details - The acquisition is part of the company's strategy to expand its offline medical institution network, aiming to increase market share in Singapore and create synergies with other offline medical institutions and online medical platforms [1] - The acquisition price was determined through fair negotiations between Gushengtang Singapore and the seller, taking into account DA ZHONG TANG's historical performance, qualifications, resources, and prospects [1] - The board believes the acquisition price represents a fair and reasonable valuation for DA ZHONG TANG [1] Group 2: Financial Implications - The acquisition cost will be funded through the net proceeds from the company's placement, idle funds of the group, and Gushengtang Singapore's own funds [1]
固生堂(02273.HK)拟收购大中堂100%股权
Ge Long Hui· 2025-11-16 11:55
Core Viewpoint - Gushengtang Singapore is acquiring 100% equity and related interests of DA ZHONG TANG PTE. LTD., which will become a subsidiary of the company, enhancing its presence in the Singapore market and expanding its offline medical network [1] Group 1 - The acquisition agreement was signed on November 16, 2025, between Gushengtang Singapore and the shareholders of DA ZHONG TANG [1] - Following the completion of the acquisition, DA ZHONG TANG will be included in the group's consolidated financial statements [1] - DA ZHONG TANG primarily provides traditional Chinese medicine services and retail pharmaceutical services in Singapore [1] Group 2 - The acquisition aligns with the company's strategy to expand its offline medical institution network through acquisitions [1] - The company anticipates that the acquisition will increase its market share in Singapore and create synergies between DA ZHONG TANG and the group's other offline medical institutions and online medical platforms [1]